Last quarter (Q4 2023), Beam Therapeutics's total revenue was $316.19M, an increase of 1478.04% from the same quarter last year. In Q4, Beam Therapeutics's net income was $142.80M. See Beam Therapeutics’s key income statements, including revenue, expenses, profit, and income.

Income Statement	TTM	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Total Revenue	$ 377.71M	$ 377.71M	$ 60.92M	$ 51.84M	$ 24.00K	$ 18.00K
Cost of Revenue	-	-	-	-	-	-
Gross Profit	$ 377.71M	$ 377.71M	$ 60.92M	$ 50.84M	-	-
Operating Expense	$ 554.19M	$ 554.19M	$ -399.40M	$ -444.31M	$ 132.78M	$ 75.17M
Operating Income	$ -176.49M	$ -176.49M	$ -338.48M	$ -393.46M	$ -132.76M	$ -75.15M
Net Non Operating Interest Income Expense	$ 9.66M	-	$ 34.20M	$ 5.14M	$ 1.05M	$ 2.23M
Other Income Expense	$ -30.06M	$ -45.32M	$ -18.60M	$ -17.69M	$ -62.88M	$ -5.40M
Pretax Income	$ -131.16M	$ -131.16M	$ -260.18M	$ -370.64M	$ -194.59M	$ -78.33M
Tax Provision	$ 1.37M	$ 1.37M	$ 3.40M	-	-	-
Earnings From Equity Interest Net Of Tax	-	-	$ -25.50M	-	-	-
Net Income Common Stockholders	$ -132.53M	$ -132.53M	$ -289.08M	$ -370.64M	$ -195.87M	$ -91.04M
Basic EPS	$ -1.87	$ -1.72	$ -4.13	$ -5.77	$ -4.19	$ -2.01
Diluted EPS	$ -1.87	$ -1.72	$ -4.13	$ -5.77	$ -4.19	$ -2.01
Basic Average Shares	$ 308.61M	$ 77.15M	$ 70.02M	$ 64.23M	$ 46.73M	$ 45.32M
Diluted Average Shares	$ 308.61M	$ 77.15M	$ 70.02M	$ 64.23M	$ 46.73M	$ 45.32M
Dividend Per Share	-	-	-	-	-	-
Total Operating Income As Reported	-	-	-	-	-	-
Reported Normalized Basic E P S	-	-	-	-	-	-
Reported Normalized Diluted E P S	-	-	-	-	-	-
Rent Expense Supplemental	-	-	-	-	-	-
Total Expenses	$ 554.19M	$ 554.19M	$ -399.40M	$ -444.31M	$ 132.78M	$ 75.17M
Net Income From Continuing And Discontinued Operation	$ -132.53M	$ -132.53M	$ -289.08M	$ -370.64M	$ -194.59M	$ -78.33M
Normalized Income	$ -20.02M	$ -97.12M	-	-	$ -131.71M	$ -72.93M
Interest Expense	-	-	-	-	-	$ 187.00K
EBIT	$ -131.16M	$ -131.16M	$ -260.18M	$ -370.64M	$ -132.76M	$ -75.15M
EBITDA	$ -111.15M	$ -111.15M	$ -246.03M	$ -363.19M	$ -128.03M	$ -71.65M

Currency in USD

Beam Therapeutics Earnings and Revenue History

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing